Monkeypox clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Study of Tecovirimat for Human Monkeypox Virus
open to all eligible people
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
San Francisco, California and other locations